In 1998, NIGMS established procedures and funding policies to ensure support for adequate numbers of new investigators defined as a research applicant who has not yet been awarded a substantial, competing NIH grant. Under these policies, an applicant's status as a New Investigator (NI) is one of the criteria used in funding decisions made by the Institute. In FY 2009, NIH announced a new policy involving the identification of Early Stage Investigators (ESIs). ESIs are New Investigators who are within 10 years of completing either their terminal research degree or their medical residency (whichever is later) at the time they apply for R01 grants.
NIGMS awarded grants to 203 New Investigators. Of these, 105 were ESIs.
Fiscal Years 2001-2011
New Investigators Funded by NIGMS on R01s
New Investigator Status Report 2011
(OER Data as FY2011 Actuals)
New (Type1) Applications and Awards
| Institute |
All investigators were new investigators |
At least one investigator was previously funded by NIH |
| Applications |
Awards |
Approximate Success Rate |
Applications |
Awards |
Approximate Success Rate |
| NIGMS |
973 |
171 |
18% |
1,408 |
222 |
16% |
| NIH |
9,446 |
1,445 |
15% |
14,412 |
2,154 |
15% |
Applicants (number of people)
| Institute |
New investigators |
Early Stage Investigators |
| Applicants |
Awardees |
Applicants |
Awardees |
| NIGMS |
1,118 |
203 |
469 |
105 |
| NIH |
10,259 |
1,787 |
4,516 |
961 |
Notes: The status of R01 and DP2 awardees is determined for the assigned fiscal year of the award. An individual PI is designated as a New investigator: If the investigator has never received a major NIH RPG competing grant award (based on definition that resides at http://grants.nih.gov/grants/new_investigators/index.htm).
Or, if the reporting fiscal year is the same as the fiscal year of the first major RPG competing grant award.
Prepared by the NIGMS Office of Program Analysis and Evaluation (OPAE).